Recently, sumoylation (Lys 527 and Lys633) was associated with the regulation of FOXK2 activity, and its role in mediating the cytotoxic response to paclitaxel through the tumor suppressor FOXO3 in breast cancer cells was recently reported (40) (Figure 3). The gene discussed is FOXO3; the disease is breast carcinoma.